Treatment of Patients Colonized With Methicillin-Resistant Staphylococcus Aureus Prior to Bone and Joint Surgery

Withdrawn before enrolling · Phase 2 · Has a placebo group

Conditions studied: Orthopedic Procedures, Methicillin-resistant Staphylococcus Aureus

In brief

The investigators anticipate that utilization of retapamulin preoperatively will eliminate MRSA colonization among patients who are colonized in their nares.

Key facts

Study ID

NCT00903279

Run by

Bay Pines VA Healthcare System

People needed

0

Starts

2009-08-01

Expected to finish

2010-12-01

Last updated by the study team

2017-01-31

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients who are admitted for an orthopedic surgical procedure
• All patients will be screened and admitted to the study prior to surgery regardless of eventual culture results for MRSA

You may not qualify if…

• Pregnancy
• Serious systemic illness due to renal, cardiac or hepatic disease
• Inability to complete follow-up assessments
• Allergy or intolerance to retapamulin
• BMI > 30
• Uncontrolled diabetes, severe anemia, thrombocytopenia or an underlying hematopoietic disorder or malignancy
• Patients with serious life-threatening illnesses and those with terminal illness not expected to survive for two years or more will not be enrolled
• Antibiotics administered during the course of the study will be recorded (name, dose and dates)

Where it is running

• Bay Pines VAHCS — Bay Pines, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.